Financials data is unavailable for this security.
View more
Year on year Cencora Inc had no change in net income (1.75bn) despite revenues that grew 9.89% from 238.59bn to 262.17bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 96.51% to 96.64%.
Gross margin | 3.37% |
---|---|
Net profit margin | 0.66% |
Operating margin | 0.89% |
Return on assets | 2.91% |
---|---|
Return on equity | 230.42% |
Return on investment | 13.38% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Cencora Inc fell by 840.65m. However, the company earned 3.91bn from its operations for a Cash Flow Margin of 1.49%. In addition the company used 2.60bn on investing activities and also paid 2.22bn in financing cash flows.
Cash flow per share | 14.80 |
---|---|
Price/Cash flow per share | 15.49 |
Book value per share | 4.70 |
---|---|
Tangible book value per share | -64.46 |
More ▼
Balance sheet in USDView more
Current ratio | 0.893 |
---|---|
Quick ratio | 0.5476 |
Total debt/total equity | 5.11 |
---|---|
Total debt/total capital | 0.8169 |
More ▼
Growth rates in USD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 5.43% and 6.06%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg) | 1.51% |
---|---|
Div growth rate (5 year) | 5.00% |
Payout ratio (TTM) | 22.28% |
EPS growth(5 years) | 12.44 |
---|---|
EPS (TTM) vs TTM 1 year ago | 12.24 |
More ▼